In addition, when we performed subgroup analyses based on ethnicity, source of controls, and quality of studies, there were again no significant results indicating a relationship between the TP53 Arg72Pro polymorphism and ovarian cancer risk. Here, TP53 is linked to ovarian carcinoma.